Induction of T regulatory cells by cytotoxic T-lymphocyte antigen-2α on corneal endothelial cells

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 5, 2011, Pages 2598-2605

  Sugita, Sunao ^a   Yamada, Yukiko ^a   Horie, Shintaro ^a   Nakamura, Orie ^b   Ishidoh, Kazumi ^c   Yamamoto, Yoshimi ^d   Yamagami, Satoru ^e   Mochizuki, Manabu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^c TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^d YAMAGUCHI UNIVERSITY   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 2ALPHA; INTERLEUKIN 2 RECEPTOR ALPHA; LYMPHOCYTE ANTIGEN; NEUTRALIZING ANTIBODY; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CONTROLLED STUDY; CORNEA CELL; CORNEA ENDOTHELIUM; DOWN REGULATION; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, NEUTRALIZING; ANTIGENS, DIFFERENTIATION; BLOTTING, WESTERN; CATHEPSIN L; CELL LINE, TRANSFORMED; ENDOTHELIUM, CORNEAL; ENZYME PRECURSORS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 79955994841     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6322     Document Type: Article

References (40)

1. Denizot F, Brunet JF, Roustan P, et al. Novel structures CTLA-2 alpha and CTLA-2 beta expressed in mouse activated T cells and mast cells and homologous to cysteine proteinase proregions. Eur J Immunol. 1989;19:631-635.
2. Reddy VY, Zhang QY, Weiss SJ. Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1995;92:3849-3853.
3. Yamamoto Y, Kurata M, Watabe S, et al. Novel cysteine proteinase inhibitors homologous to the proregions of cysteine proteinases. Curr Protein Pept Sci. 2002;3:231-238.
4. Kurata M, Hirata M, Watabe S, et al. Expression, purification, and inhibitory activities of mouse cytotoxic T-lymphocyte antigen-2alpha. Protein Expr Purif. 2003;32:119-125.
5. Futagami Y, Sugita S, Vega J, et al. Role of thrombospondin-1 in T cell response to ocular pigment epithelial cells. J Immunol. 2007; 178:6994-7005.
6. Sugita S, Horie S, Nakamura O, et al. Retinal pigment epitheliumderived CTLA-2alpha induces TGFbeta-producing T regulatory cells. J Immunol. 2008;181:7525-7536.
7. Sugita S, Horie S, Nakamura O, et al. Acquisition of T regulatory function in cathepsin L-inhibited T cells by eye-derived CTLA-2alpha during inflammatory conditions. J Immunol. 2009;18: 5013-5022.
8. Luziga C, Nakamura O, Deshapriya RM, et al. Expression mapping of cytotoxic T-lymphocyte antigen-2alpha gene transcripts in mouse brain. Histochem Cell Biol. 2007;127:569-579.
9. Cheon YP, DeMayo FJ, Bagchi MK, Bagchi IC. Induction of cytotoxic T-lymphocyte antigen-2beta, a cysteine protease inhibitor in decidua: a potential regulator of embryo implantation. J Biol Chem. 2004;279:10357-10363.
10. Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol. 2003;3:879-889.
11. Sugita S. Role of ocular pigment epithelial cells in immune privilege. Arch Immunol Ther Exp (Warsz). 2009;57:263-268.
12. Sugita S, Usui Y, Horie S, et al. Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism. Invest Ophthalmol Vis Sci. 2009;50:263-272.
13. + T cells by human corneal endothelial cells via membrane-bound TGFβ. Invest Ophthalmol Vis Sci. 2010;51: 2548-2557.
14. Hatou S, Yamada M, Mochizuki H, Shiraishi S, Joko T, Nishida T. The effects of dexamethasone on the Na, K-ATPase activity and pump function of corneal endothelial cells. Curr Eye Res. 2009; 34:347-354.
15. Sugita S, Streilein JW. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2003; 198:161-171.
16. Sugita S, Ng TF, Schwartzkopff J, Streilein JW. CTLA-4+CD8+ T cells that encounter B7-2+ iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation. J Immunol. 2004;172:4184-4194.
17. Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA. A role for TGFbeta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol. 2001;166:7282-7289.
18. Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25+ naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. 2003;198:1875-1886.
19. Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270: 1189-1192.
20. Yamagami S, Kawashima H, Tsuru T, et al. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation. 1997;64:1107-1111.
21. Cursiefen C. Immune privilege and angiogenic privilege of the cornea. Chem Immunol Allergy. 2007;92:50-57.
22. Taylor AW, Streilein JW, Cousins SW. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J Immunol. 1994;153:1080-1086.
23. Taylor AW. Ocular immunosuppressive microenvironment. Chem Immunol Allergy. 2007;92:71-85.
24. Sugita S, Ng TF, Lucas PJ, et al. B7+ iris pigment epithelium induce CD8+ T regulatory cells: both suppress CTLA-4+ T cells. J Immunol. 2006;176:118-127.
25. Taylor AW, Alard P, Yee DG, Streilein JW. Aqueous humor induces transforming growth factor-beta (TGF-beta)-producing regulatory T-cells. Curr Eye Res. 1997;16:900-908.
26. Sugita S, Usui Y, Horie S, et al. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions. Invest Ophthalmol Vis Sci. 2009;50:2862-2870.
27. Horie S, Sugita S, Futagami Y, et al. Human iris pigment epithelium suppresses activation of bystander T cells via TGFβ-TGFβ receptor interaction. Exp Eye Res. 2009;88:1033-1042.
28. Usui Y, Okunuki Y, Hattori T, et al. Functional expression of B7H1 on retinal pigment epithelial cells. Exp Eye Res. 2008;86:52-59.
29. Cousins SW, McCabe MM, Danielpour D, Streilein JW. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci. 1991;32: 2201-2211.
30. Granstein RD, Staszewski R, Knisely TL, et al. Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation. J Immunol. 1990;144:3021-3027.
31. Sugita S, Futagami Y, Smith SB, et al. Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor beta. Exp Eye Res. 2006;83:1459-1471.
32. Caspi RR, Roberge FG, Nussenblatt RB. Organ-resident, nonlymphoid cells suppress proliferation of autoimmune T-helper lymphocytes. Science. 1987;237:1029-1032.
33. Kawashima H, Gregerson DS. Corneal endothelial cells block T cell proliferation, but not T cell activation or responsiveness to exogenous IL-2. Curr Eye Res. 1994;13:575-585.
34. Kawashima H, Prasad SA, Gregerson DS. Corneal endothelial cells inhibit T cell proliferation by blocking IL-2 production. J Immunol. 1994;153:1982-1989.
35. Walker MR, Kasprowicz DJ, Gersuk VH, et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25-T cells. J Clin Invest. 2003;112:1437-1443.
36. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235-238.
37. Davidson TS, DiPaolo RJ, Andersson J, Shevach EM. Cutting edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J Immunol. 2007;178:4022-4026.
38. DiPaolo RJ, Brinster C, Davidson TS, et al. Autoantigen-specific TGFβ-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J Immunol. 2007;179:4685-4693.
39. Sugita S, Futagami Y, Horie S, Mochizuki M. Transforming growth factor beta-producing Foxp3(+)CD8(+)CD25(+) T cells induced by iris pigment epithelial cells display regulatory phenotype and acquire regulatory functions. Exp Eye Res. 2007;85:626-636.
40. Hori J, Wang M, Miyashita M, et al. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol. 2006;177:5928-5935.